CD276 and cancer: When investigating the relationship between immune checkpoint expression and PSME3, we observed that among the 33 cancers, CD276 and CD274 exhibited the highest positive correlation with PSME3, followed by VEGFA, HMGB1, THR4, BTNA2, and ENTDD1 (Figure 6D).